Long‐term outcome of juvenile idiopathic arthritis following a placebo‐controlled trial: sustained benefits of early sulfasalazine treatment

OBJECTIVES: A previous 24‐week randomised trial demonstrated that sulfasalazine (SSZ) treatment was superior to placebo (PLAC) in suppressing disease activity in patients with oligo‐ and polyarticular onset juvenile idiopathic arthritis (JIA). The current study determines the long‐term outcome of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: van Rossum, Marion A J, van Soesbergen, Renée M, Boers, Maarten, Zwinderman, Aeilko H, Fiselier, Theo J W, Franssen, Marcel J A M, Cate, Rebecca ten, van Suijlekom‐Smit, Lisette W A, Wulffraat, Nico M, van Luijk, Wilma H J, Oostveen, Johanna C M, Kuis, Wietse, Dijkmans, Ben A C
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2007
Témata:
Extended Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2111611/
https://ncbi.nlm.nih.gov/pubmed/17491099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.064717
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
Načítá se...

Podobné jednotky